Neuromuscular junction disease: myasthenia gravis and botulism
- Understand the difference between the pathophysiology of acquired myasthenia gravis and botulism
- Apply the best diagnostic and treatment for patients with neuromuscular junction disease
Dr. Pablo Amengual graduated from the Universitat Autònoma de Barcelona in 2012, followed by a rotating small animal internship at the same institution.
He worked in general practice for 6 months before moving to the UK. HE completed a 6-month externship in Neurology and a second rotating small animal internship, both at the Hospital for Small Animals of the University of Edinburgh.
In 2016, he began a residency in Neurology/Neurosurgery at the Small Animal Hospital of the University of Glasgow.
In 2019, he joined the Neurology Service of the Hospital for Small Animals as Lecturer in Neurology. He was awarded the diploma of the European College of Veterinary Neurology in 2020.
He worked in general practice for 6 months before moving to the UK. HE completed a 6-month externship in Neurology and a second rotating small animal internship, both at the Hospital for Small Animals of the University of Edinburgh.
In 2016, he began a residency in Neurology/Neurosurgery at the Small Animal Hospital of the University of Glasgow.
In 2019, he joined the Neurology Service of the Hospital for Small Animals as Lecturer in Neurology. He was awarded the diploma of the European College of Veterinary Neurology in 2020.